Research Journal of Pharmacy and Technology
SCOPUS
  • Year: 2021
  • Volume: 14
  • Issue: 11

3d atom based qsar model of dprel inhibitors as anti-tubercular agents

  • Author:
  • K. Poojita1, Fajeelath Fathima1, Rajdeep Ray1, Lalit Kumar2, Ruchi Verma1
  • Total Page Count: 8
  • Page Number: 5903 to 5910

1Department of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences, Manipal academy of Higher Education, Madhav Nagar-576104, Manipal, Udupi, Karanataka, India

2Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal academy of Higher Education, Madhav Nagar-576104, Manipal, Udupi, Karanataka, India

*Corresponding Author E-mail: ruchi.verma@manipal.edu, ruchiverma_farma@yahoo.com

Online Published on 22 February, 2022.

Abstract

Tuberculosis disease is world's biggest threat to health with a high mortality rate. There has been a steady surge in the frequency of MDR-TB and XDR-TB. Hence, it is imperative to encourage the research and development of novel drugs to counteract the infection. Decaprenylphosphoryl-fi-D-ribose-2’a-epimerase 1 (DprEl) is a valuable enzyme which is responsible for the stability and virulence of the infection causing bacteria (Mycobacterium tuberculosis) thereby making it a perfect target for drugs anti TB activity. This study represent atom based 3D QSAR model consisting the derivatives of DprEl inhibitors and provides guidance and insight to develop and identify new novel molecule which have good therapeutic efficiency as Anti TB drugs.

Keywords

DprEl, Mycolic acid, Mycobacterium tuberculosis, Atom based 3D QSAR, MDR-TB